Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 22.54B | 22.77B | 23.59B | 24.79B | 24.66B |
Gross Profit | 6.25B | 5.72B | 5.30B | 5.04B | 4.86B |
EBITDA | 2.29B | 1.92B | 1.80B | 1.65B | 1.58B |
Net Income | 1.15B | 895.00M | 748.00M | 602.00M | 736.00M |
Balance Sheet | |||||
Total Assets | 25.56B | 24.24B | 22.81B | 22.29B | 22.82B |
Cash, Cash Equivalents and Short-Term Investments | 5.92B | 10.35B | 8.43B | 7.40B | 8.72B |
Total Debt | 923.00M | 532.00M | 660.00M | 874.00M | 1.36B |
Total Liabilities | 5.69B | 5.06B | 4.98B | 4.95B | 6.01B |
Stockholders Equity | 19.87B | 19.18B | 17.83B | 17.34B | 16.81B |
Cash Flow | |||||
Free Cash Flow | -415.00M | 2.42B | 1.53B | -694.00M | 369.00M |
Operating Cash Flow | 359.00M | 2.97B | 1.74B | -187.00M | 725.00M |
Investing Cash Flow | -6.42B | -527.00M | -201.00M | -561.00M | 245.00M |
Financing Cash Flow | -590.00M | -523.00M | -518.00M | -569.00M | -563.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥16.93B | 13.70 | 3.42% | 1.83% | 19.05% | ||
77 Outperform | ¥17.05B | 14.89 | 2.16% | -1.02% | 27.93% | ||
76 Outperform | ¥14.52B | 16.91 | 1.23% | 6.22% | 29.99% | ||
69 Neutral | ¥13.96B | 13.63 | 4.63% | 4.11% | -5.13% | ||
63 Neutral | ¥16.15B | 145.95 | 2.41% | 4.02% | -87.61% | ||
63 Neutral | $34.93B | 5.90 | -12.00% | 2.00% | 5.61% | -19.55% |